I looked at some old Clinicaltrials.gov for MSB trials a couple of months ago and noticed some old trial records had been updated recently. I looked at one or two and it seemed the main change was in treatment product naming - from historical names Prochymal/MSC-100-IV to current names remestemcel-L/Ryoncil. So just trying to reduce brand confusion with the newly trademarked names?
I looked at some old Clinicaltrials.gov for MSB trials a couple...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |